| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |